392 results about "Swertia" patented technology

Nutritional supplement drink compositions containing extracted xanthones, flavoring agents, aqueous carriers, and one or more vitamins, minerals, carotenoids, flavonoids, or other nutrients are described. The xanthones are extracted from xanthone-rich plants, such as the mangosteen tree, Brazilian malva-do-santo, and a Chinese herb, Swertia davidi.

A method of treating non-insulin dependent diabetes mellitus comprising the step of providing a composition comprising a predetermined amount of berberine and a predetermined amount of catalpol, wherein said berberine and said catalpol are major active ingredients of said composition. The composition may further comprise a predetermined amount of oleanolic acid as another active ingredient. The berberine is obtained from natural herbs selected from the group of Berberis, Chelidonium, Stephniz, Coptis, Phellodendron, and Ziziphus, the catalpol is obtained from natural herbs selected from the group of Rehmannia, Verbascum, Panulownia, Glubularia and Adonis, and the oleanolic acid is obtained from natural herbs selected from the group of Olea, Swertia, Astrantia, Lonicera and Beta.

A nutritional supplement composition containing extracted xanthones, vitamins, minerals, carotenoids, flavonoids, and other nutrients is described. The xanthones are extracted from xanthone-rich plants, such as the mangosteen tree, Brazilian malva-do-santo, and a Chinese herb, Swertia davidi.

The invention provides a Chinese medicament for preventing and treating calf diarrhea. The Chinese medicament comprises bighead atractylodes rhizome, dried ginger, indigo naturalis, pomegranate peel, coptis, astragalus root, anemarrhenae, self-heal, roasted white hyacinth bean, jujube, polygonatum kingianum, hairy euphorbia, myrobalan, folium microcotis, resurrection lily rhizome, schisandra, atractylodes, gordon euryale, cherokee rose fruit, changium smyrnioides, tuckahoe, adenophora tetraphylla, limonite and swertia herb. A calf using the Chinese medicament has strong resistance, the diarrhea incidence is low, the cure rate is high, and the treatment course is short; and the Chinese medicament and a feed have the advantages of low price, low toxic or side effect, low medicament resistance and low medicament residue.

The invention discloses a traditional Chinese medicine for treating apoplexy sequela, hypertension, hyperlipidemia and hyperviscosemia. The traditional Chinese medicine is prepared from the following bulk pharmaceutical chemicals as active ingredients in parts by weight: 100-120 parts of radix astragali seu hedysari, 10-15 parts of radix paeoniae rubra, 10-12 parts of herbs of false chinese swertia, 8-10 parts of rhizoma ligustici chuanxiong, 8-10 parts of semen persicae, 3-5 parts of flos carthami, 8-10 parts of lumbricus, 20-25 parts of radix salviae miltiorrhizae, 8-10 parts of hirudo, 10-15 parts of radix dipsaci, 12-15 parts of herba taxilli, 8-10 parts of cortex eucommiae, 28-30 parts of raw hawthorn, 4-5 parts of ramulus cinnamomi, 8-10 parts of bulbus allii macrostemonis, 12-15 parts of radix cyathulae, 18-20 parts of radix puerariae, 5-6 parts of scorpio, 28-30 parts of folium ginkgo, 25-30 parts of herba erigernotis, 8-10 parts of rhizoma alismatis, 28-30 parts of poria, 25-30 parts of semen ziziphi spinosae, 18-20 parts of semen cassiae, 18-20 parts of scorched medicated leaven and 10-15 parts of fructus ligustri lucidi. The traditional Chinese medicine can achieve the efficacies of invigorating qi and promoting blood circulation, promoting circulation and removing stasis, stimulating the menstruational flow and dissipating the phlegm, and tonifying the kidney and reducing the blood pressure, and is a first-choice medicament of the patients with apoplexy sequela, hypertension, hyperlipidemia and hyperviscosemia, and has obvious treatment effect.

The invention relates to a traditional Chinese medicine disinfectant and a preparation method thereof. The raw materials for preparing effective components of the disinfectant comprise: fructus piperis longi, lithargite, dendrobium, bee venom, emblic leafflower leaf, xanthorrhiza, saururus chinensis, the bark of ash, camphortree leaf, swallow tail, nephelium lappaceum, mile swertia, fungus-infected rice spike, chicory, folium sennae and greater celandine. The traditional Chinese medicine disinfectant disclosed by the invention is strong in bactericidal ability, high in acting speed, strong in stability, free of stimulation on skin of a human body, easy to dissolve into water, free of residue after use, safe and free of toxic and side effects, can be widely applied to sterilization of skin of clinical laboratory personnel, medical apparatus and instruments, medical places and the like, and is an ideal disinfectant worth spreading.

A method of restoring insulin beta cells in a living object to lower a plasma sugar level comprising the step of providing a composition of berberine and catalpol as the two major active ingredients of said composition. The composition is preferably include oleanolic acid and taurine as active ingredients. The composition is pre-made into a single dosage unit. The single dosage contains active ingredients within a range between 1 to 300 mg/kg/dl for a single intake and is in a form of packet powders, solution in vials, ampoules or pre-filled syringes, capsule, tablet, draught in water, syrup and/or cachets. The berberine is obtained from natural herbs Berberis, Chelidonium, Stephniz, Coptis, Phellodendron, and/or Ziziphus, the catalpol is obtained from natural herbs Rehmannia, Verbascum, Panulownia, Glubularia and/or Adonis. The oleanolic acid is obtained from natural herbs Olea, Swertia, Astrantia, Lonicera and/or Beta.

The invention provides a method for preparing hepatitis-resisting active sites mainly from medicinal herbal Swertiamarin, which comprises: (1) disintegrating and extracting in water or water hydrophilic organic solvent through backflow, filtering to obtain merged concentration liquid, freezing, centrifugally filtrating, obtaining extract, (2) passing through macroscopic adsorption resin columns, (3) water scrubbing the resin columns, purging with 10-70% ethanol or methanol, collecting the eluent and concentrating.

The invention discloses a Chinese patent medicament for treating acute and chronic viral hepatitis type B, and relates to a Chinese medicament composition, in particular to a Chinese patent medicament for treating the acute and chronic viral hepatitis type B and ascites due to cirrhosis. The Chinese patent medicament is a Chinese medicinal formulation which is prepared from the following Chinese herbal medicine raw materials in portion by weight: 20 to 30 portions of Artemisia capillaris, 15 to 30 portions of cairo morningglory root, 25 to 30 portions of Zornia diphylla, 20 to 25 portions of Astragalus membranaceus, 15 to 20 portions of Paeonia lactiflora, 10 to 12 portions of bupleurum, 6 to 8 portions of liquorice, 0 to 15 portions of swertia, 8 to 10 portions of cape jasmine, 20 to 25 portions of stringy stonecrop and 20 to 25 portions of European verbena. The formulation can be powders, pills, tablets, medicinal granules, capsules and oral liquid.

The present invention relates to a kind of Chinese medicine for treating hepatitis, especially chronic active hepatitis, and cholecystitis and its preparation process. The Chinese medicine is prepared with false Chinese swertia herb, common pecteilis root, lysimachia, rhubarb, astragalus root and other seven kinds of Chinese medicinal materials. It may be prepared into different clinically acceptable preparation forms. Clinical test proves its obvious curative effect on hepatitis and cholecystitis and no toxic side effect.

A medicine for antibacterial purpose and treating hypercholesterolemia and atherosclerosis is prepared from twospot swertia herb, and contains one or more of demethyl gentianone of daisy leaf, gentianone of daisy leaf, etc.

A composite medicine for treating hepatitis and diabetes is prepared from twospot swertia herb through extracting its active components (oleanolic acid, etc).

The invention discloses a radix gentianae compound enzyme preparation method, which comprises: S10, selecting fresh radix gentianae, swertia and centella asiatica, crushing, screening, and adding deionized water to dissolve the screened powder so as to obtain a dissolving solution; S20, adding cellulase and pectinase into the dissolving solution for enzymolysis treatment, and obtaining enzymatic hydrolysate; S30, adding yeast extract, peptone and glucose into the enzymatic hydrolysate, and then performing sterilization treatment to obtain a sterilized solution; and S40, inoculating a strain combination consisting of saccharomyces cerevisiae and lactobacillus plantarum into the sterilized solution, and performing fermentation treatment to obtain the radix gentianae compound enzyme. The radix gentianae compound enzyme prepared by the method disclosed by the invention is high in content of effective substances, can be applied to daily chemical products to strengthen skin functions and improve skin conditions, and has very good anti-allergy soothing and anti-oxidation effects.

The invention provides a traditional Chinese medicine composition for curing herpes simplex viral keratitis. Bulk drugs of the traditional Chinese medicine composition include butterflybush flowers, eriocaulon buergerianum, flatstem milkvetch seeds, fructus broussonetiae, calamine, barks of ash, folium mori, centipeda minima, groundsel, fruit of glossy privet, isatis roots, ginseng leaves, astragalus mongholicus, radix paeoniae alba, radix bupleuri, coptis chinensis, mulberries, piemarker, leonurus, roots of red-rooted salvia, poria cocos, mile swertia, plantain herb and concha haliotidis. The traditional Chinese medicine composition for curing herpes simplex viral keratitis can be used for adjusting the immune system, improves the immunologic function, is anti-inflammatory and antiviral, effectively avoids recurrence, and has the advantages of improving the curative effect, shortening the treatment course, reducing the recurrence rate and complication and quickening the vision recovery compared with simple western medicine treatment.

The invention provides a traditional Chinese medicine preparation for treating neurasthenia and a preparation method thereof. The traditional Chinese medicine preparation for treating the neurasthenia is prepared from medicinal raw materials which include spiranthes sinensis ames, gray vernonia, skyblue broomrape herb, aleuritopteris argentea fee, alpine swertia, Chinese alpine rush, whorledleaf solomonseal rhizome, cynanchum thesioides, celastrus orbiculatus, obcordateleaf raspberry fruit, telegraph plant, lanceleaf magnoliavine fruit, ginseng fruit, cypripedium guttatum, hemiphragma heterophyllum, Cassiope selaginoides Hook.F.Et Thoms. and red rhodobryum. The traditional Chinese medicine preparation for treating the neurasthenia has the effects of clearing away heat and toxic materials, promoting blood circulation to restore menstrual flow, tonifying qi and yin, calming the mind, soothing the nerves, nourishing the liver and the kidney, treating the root cause and symptoms of a disease and has a definite curative effect and a small side effect.

The invention relates to a traditional Chinese medicine for treating tinnitus. The Chinese medicine for treating tinnitus is prepared from scarlet swertia herb, acorus gramineus, buckwheat leaves, mahonia bealei carr, lousewort roots, rust-coloured crotalaria herb with roots, deer-horn glue, black sesame seeds, selfheal, prepared rhizome of rehmannia, mulberry fruit, and bunge auriculate roots. The traditional Chinese medicine can be clinically used for treating tinnitus.

A Mongolian medicine in the form of particle, pill, capsule, tablet, or powder for treating chronic cholecystitis and cholecystalgia is prepared from two-spot swertia herb, lateripening bartsia herb, picrorhiza rhizome and capejasmine fruit. Its preparing process is also disclosed.

The invention discloses bone-strengthening medicinal liquor, and belongs to traditional Chinese medicine health care liquor. The medicinal liquor is prepared by infusing traditional Chinese medicines prepared according to the following traditional Chinese medicine formula in liquor; according to the traditional Chinese medicine formula, a main formula comprises: 60 g of twoleaf swertia herbs, 30 g of aristolochia mollissima, 20 g of radix cyathulae, 60 g of vinegar-processed radix clematidis, 60 g of woodlouse, 20 g of eucommia, 25 g of radix aconiti preparata, 25 g of prepared kusnezoff monkshood roots, 20 g of phryma leptostachya, 20 g of herba epimedii, 60 g of radix dipsaci, 60 g of rhizoma drynariae, 100 g of native copper, 60 g of caulis spatholobi, 30 g of frankincense, 10 g of pawpaw, 20 g of philippine flemingia roots, 15 g of white peony roots, 15 of centipede, 15 g of scorpion, 3 pieces of prepared nux vomica, 20 g of bombyx batryticatus, 10 g of cornua cervi pantotrichum, 1 pair of sea horses, 15 g of deer's sinew, 15 g of rhizoma corydalis, 10 g of dragon's blood, 20 g of long-noded pit viper, and 15 g of myrrh; an assistant formula comprises: 25 g of girald daphne bark, 30 g of scorpion, 15 g of uncaria, 15 g of rhizoma gastrodiae, 20 g of catharanthus roseus, 25 g of carpesium abrotanoides, 15 g of ramulus mori, 10 g of cassia twig, 35 g of radix puerariae, 60 g of rhizoma cibotii, and 10 g of semen brassicae. The bone-strengthening medicinal liquor of the invention has good curative effect, quick effect, high cure rate, low recurrence rate, and no side effect with respect to lumbar vertebra and cervical vertebra hyperplasia, hyperosteogeny, osteoporosis, rheumatoid arthritis, and the like.

The invention relates to an anti-cancer drug composition containing amentoflavone. The drug composition adopts the amentoflavone, swertiamarin, syringopicroside and false Chinese swertia herb as bulk drugs which are matched to prepare various dosage forms according to the conventional preparation technology. The drug composition provided by the invention has significance on preparing anti-cancer drug, especially anti-hepatoma drug, anti-lung cancer drug and anti-gastric caner drug.

The invention relates to traditional Chinese medicine lotion for treating gynecological inflammations as well as a preparation method thereof. The effective components of the traditional Chinese medicine lotion are prepared from prepared rehmannia root, plant soot, memorialis, radix angelicae, hairyvein agrimony, frankincense, vervain, sunglo, Polygonum cuspidatum, leaves of Ringworm Senna, Gelsmium elegans, purslane, Japanese balanophora, silverleaf cinquefoil roots, elongated swertia herb and sophora flavescens. The traditional Chinese medicine lotion provided by the invention is prepared by adopting a modern advanced medical pharmaceutical technology. The selected medicinal materials are good in medicine compatibility and meet the theories of traditional Chinese medicines and modern medicines, so that the lotion has the functions of killing bacteria, diminishing inflammation and relieving itching and pain, has a remarkable curative effect on gynecological inflammations such as peculiar smells, stickness and heart-scratching caused by various bacterial propagation of females, and is capable of adjusting and maintaining the ecological balance of floras in the private parts of females. The lotion is mild, nonirritant, free of toxic and side effects, and worth wide popularization and application.

The invention relates to a traditional Chinese medicine composition for treating endocrine dyscrasia. The traditional Chinese medicine composition is prepared from the following raw medicinal materials in parts by weight: 10-20 parts of chrysanthemum, 10-30 parts of mulberry, 10-20 parts of dried human placenta, 20-40 parts of radix rehmanniae, 10-20 parts of songaria cynomorium herb, 20-40 parts of all-grasses of desertliving cistanche, 10-20 parts of common anemarrhena rhizome, 10-20 parts of indigowoad leaf, 6-18 parts of root of manyflower glorybower, 10-30 parts of spina date seed, 5-15 parts of root of thinleaf milkwort, 5-15 parts of all-grass of diverseflower swertia, 20-40 parts of lily, 20-40 parts of prepared polygonum multiflorum, 10-30 parts of tuner onion seed, 10-30 parts of pilose antler, 6-18 parts of cortex moutan, 10-20 parts of turtle shell, 20-40 parts of salvia, 10-30 parts of ligusticum wallichii, 10-30 parts of radix paeoniae alba and 10-20 parts of flastem milkvetch seed. The traditional Chinese medicine composition has the efficacies of tonifying liver and kidney, supplementing qi, promoting production of body fluid, invigorating circulation of blood, dispelling wind, eliminating dampness, replenishing vital essence, nourishing blood, dispersing blood stasis and promoting meridian and blood and is remarkable in curative effect of treating endocrine dyscrasia and reliable in effect.

The invention discloses a skin-care composition, cosmetic with a pore minimizing effect and a preparation method thereof and belongs to the technical field of cosmetics. The skin-care composition is prepared from false Chinese swertia herb, fomitopsis officinalis, herba dendrobii, rhizoma alismatis and liquorice root; the weight ratio of the false Chinese swertia herb to the fomitopsis officinalisto the herba dendrobii to the rhizoma alismatis to the liquorice root is (1 to 5) to (1 to 5) to (1 to 5) to (1 to 3) to (1 to 5). The skin-care composition provided by the invention has an aromaticflavor and a relatively good skin feeling; the skin-care composition is added into cosmetics including gel, cream, lotion, cleansing milk, cleansing cream, shampoo, toner or firming lotion, mask, bathlotion and the like; a reasonable adding amount and proper technological conditions are controlled and a tissue structure of the cosmetics is not damaged; adverse effects on the stability of the cosmetics are not caused, and quality problems including color changing, layering and the like are not caused.

The invention relates to a false Chinese swertia herb extract, a preparation method and an application thereof. The method takes false Chinese swertia herb as raw material, and the false Chinese swertia herb extract which contains more than 50 percent of secoiridoid compounds, more than 40 percent of single ingredient of swertiamain and more than 45 percent of three ingredients of chiratin, gentiopicroside, and the like, is obtained by using only one step of the macroporous absorption resin purification process after the extraction. The extract has significant effects on the protection, the prevention and the treatment of liver injury. The product has simple method and operation, high product yield, good repeatability and strong feasibility.

The invention discloses herbal tea for preventing upper respiratory tract infection. The herbal tea is characterized by being prepared from the following active pharmaceutical ingredients in parts by weight: 14 to 20 parts of common bluebeard herbs, 10 to 16 parts of strongfragrant loosestrife herbs with roots, 10 to 16 parts of flos lonicerae, 10 to 16 parts of folia mori, 6 to 10 parts of apricot seeds, 14 to 20 parts of herba dendrobii, 14 to 20 parts of myriogyne minuta less, 1 to 2 part(s) of eucalypti folium, 3 to 5 parts of large twoleaf swertia herbs and 50 to 200 parts of tea. Clinical researches prove that the herbal tea has the characteristics of good effect and higher safety.

The invention relates to a traditional Chinese medicine for treating liver fibrosis. The traditional Chinese medicine is prepared from the following crude drugs in parts by weight: 12 parts of urena procumbens, 14 parts of pavettahongkongensis, 12 parts of root of coix lacryma-jobi ma-yuen, 10 parts of largeleaf violet herb, 9 parts of rock orchid, 8 parts of alpine swertia, 8 parts of orixa japonica, 8 parts of cynanchum auriculatum royle, 14 parts of vermiculate thamnolia thallus, 12 parts of anderson cirrhopetalum herb, 10 parts of tiarella polyphylla, 14 parts of wight parnassia herb, 12 parts of panax bipinnatifidus seem, 10 parts of japanese creeper, 12 parts of thorn pear, 12 parts of wedelia chinensis, 14 parts of rock balls, 12 parts of pilea cavaleriei, and 12 parts of stink wellington. A clinical experiment shows that the traditional Chinese medicine can safely and effectively treat the liver fibrosis.